ArticleOncoTargets and therapy2016

Prognostic implications of immunohistochemistry markers for EGFR-TKI therapy in Chinese patients with advanced lung adenocarcinoma harboring EGFR mutations.

Ruiguang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.